Regulated differentiation of stem cells into an artificial 3D liver as a transplantable source

키워드

참고문헌 (111)

1. Xu J, "Deaths : final data for 2016", Natl Vital Stat Rep, 67, pp.1~76 (2018)
2. Tsochatzis EA, "Liver cirrhosis", Lancet, 383, pp.1749~1761 (2014)
3. Crager S, "Critically ill patients with end-stage liver disease", Emerg Med Clin North Am, 37, pp.511~527 (2019)
4. Meirelles Júnior RF, "Liver transplantation: history, outcomes and perspectives", Einstein (Sao Paulo), 13, pp.149~152 (2015)
5. Berendsen TA, "Supercooling enables long-term transplantation survival following 4 days of liver preservation", Nat Med, 20, pp.790~793 (2014)
6. Takayama K, "Generation of safe and therapeutically effective human induced pluripotent stem cell-derived hepatocyte-like cells for regenerative medicine", Hepatol Commun, 1, pp.1058~1069 (2017)
7. Fu Y, "Rapid generation of functional hepatocyte-like cells from human adiposederived stem cells", Stem Cell Res Ther, 7, pp.105~ (2016)
8. Liu QW, "Therapeutic efficiency of human amniotic epithelial stem cell-derived functional hepatocyte-like cells in mice with acute hepatic failure", Stem Cell Res Ther, 9, pp.321~ (2018)
9. Nagamoto Y, "Transplantation of a human iPSC-derived hepatocyte sheet increases survival in mice with acute liver failure", J Hepatol, 64, pp.1068~1075 (2016)
10. Wang H, "Compact bone-derived mesenchymal stem cells attenuate nonalcoholic steatohepatitis in a mouse model by modulation of CD4 cells differentiation", Int Immunopharmacol, 42, pp.67~73 (2017)
11. Ranucci G, "Wilson’s disease : prospective developments towards new therapies", World J Gastroenterol, 23, pp.5451~5456 (2017)
12. Wu DB, "Stem cell transplantation for the treatment of end-stage liver disease", World J Hepatol, 10, pp.907~910 (2018)
13. Saad El-Din S, "Impact of mesenchymal stem cells and vitamin D on transforming growth factor beta signaling pathway in hepatocellular carcinoma in rats", Asian Pac J Cancer Prev, 19, pp.905~912 (2018)
14. Haga H, "Extracellular vesicles from bone marrow-derived mesenchymal stem cells improve survival from lethal hepatic failure in mice", Stem Cells Transl Med, 6, pp.1262~1272 (2017)
15. Lu WY, "Hepatic progenitor cells of biliary origin with liver repopulation capacity", Nat Cell Biol, 17, pp.971~983 (2015)
16. Muguruma K, "3D Culture for self-formation of the cerebellum from human pluripotent stem cells through induction of the isthmic organizer", Methods Mol Biol, 1597, pp.31~41 (2017)
17. Takebe T, "Massive and reproducible production of liver buds entirely from human pluripotent stem cells", Cell Rep, 21, pp.2661~2670 (2017)
18. Takebe T, "Vascularized and complex organ buds from diverse tissues via mesenchymal cell-driven condensation", Cell Stem Cell, 16, pp.556~565 (2015)
19. Takebe T, "Vascularized and functional human liver from an iPSC-derived organ bud transplant", Nature, 499, pp.481~484 (2013)
20. Xie PY, "Generation of functional hepatocyte-like cells from human bone marrow mesenchymal stem cells by overexpression of transcription factor HNF4α and FOXA2", Hepatobiliary Pancreat Dis Int, 18, pp.546~556 (2019)
21. Xue G, "Effect of microenvironment on differentiation of human umbilical cord mesenchymal stem cells into hepatocytesin vitroandin vivo", Biomed Res Int, 2016, pp.8916534~ (2016)
22. Du C, "Highly efficient and expedited hepatic differentiation from human pluripotent stem cells by pure small-molecule cocktails", Stem Cell Res Ther, 9, pp.58~ (2018)
23. Pettinato G, "Generation of fully functional hepatocyte-like organoids from human induced pluripotent stem cells mixed with endothelial cells", Sci Rep, 9, pp.8920~ (2019)
24. Nie YZ, "Recapitulation of hepatitis B virus-host interactions in liver organoids from human induced pluripotent stem cells", EBioMedicine, 35, pp.114~123 (2018)
25. Fukuda T, "Isolation and expansion of human pluripotent stem cell-derived hepatic progenitor cells by growth factor defined serum-free culture conditions", Exp Cell Res, 352, pp.333~345 (2017)
26. Luckert C, "Comparative analysis of 3D culture methods on human HepG2 cells", Arch Toxicol, 91, pp.393~406 (2017)
27. Mazza G, "Engineering in vitro models of hepatofibrogenesis", Adv Drug Del Rev, 121, pp.147~157 (2017)
28. Yan C, "Activation of hepatic stellate cells during liver carcinogenesis requires fibrinogen", integrin αvβ5 in zebrafish, 2018, pp.20, 533~542
29. Saito Y, "Mechanism of impairment on liver regeneration in elderly patients : role of hepatic stellate cell function", Hepatol Res, 47, pp.505~513 (2017)
30. Geerts A, "On the origin of stellate cells: mesodermal, endodermal or neuro-ectodermal?", J Hepatol, 40, pp.331~334 (2004)
31. Baba S, "Commitment of bone marrow cells to hepatic stellate cells in mouse", J Hepatol, 40, pp.255~260 (2004)
32. Asahina K, "Hepatic stellate cell progenitor cells", J Gastroenterol Hepatol, 27, pp.80~84 (2012)
33. Tan KS, "Expression of cytokine and extracellular matrix mRNAs in fetal hepatic stellate cells", Genes Cells, 22, pp.836~844 (2017)
34. Kordes C, "Beyond fibrosis : stellate cells as liver stem cells", Z Gastroenterol, 53, pp.1425~1431 (2015)
35. Coll M, "Generation of hepatic stellate cells from human pluripotent stem cells enables invitro modeling of liver fibrosis", Cell Stem Cell, 23, pp.101~113.e7 (2018)
36. Xu M, "Key role of liver sinusoidal endothelial cells in liver fibrosis", Biosci Trends, 11, pp.163~168 (2017)
37. Poisson J, "Liver sinusoidal endothelial cells : physiology and role in liver diseases", J Hepatol, 66, pp.212~227 (2016)
38. Ni Y, "Pathological process of liver sinusoidal endothelial cells in liver diseases", World J Gastroenterol, 23, pp.7666~7677 (2017)
39. DeLeve LD, "Liver sinusoidal endothelial cell : an update", Semin Liver Dis, 37, pp.377~387 (2017)
40. Du C, "Induced pluripotent stem cell-derived hepatocytes and endothelial cells in multi-component hydrogel fibers for liver tissue engineering", Biomaterials, 35, pp.6006~6014 (2014)
41. Vunjak-Novakovic G, "HeLiVa platform : integrated heart-liver-vascular systems for drug testing in human health and disease", Stem Cell Res Ther, 4(Suppl 1), pp.S8~ (2013)
42. Narmada BC, "Human stem cell-derived endothelial-hepatic platform for efficacy testing of vascular-protective metabolites from nutraceuticals", Stem Cells Transl Med, 6, pp.851~863 (2017)
43. Rubio-Tomás T, "Genetic lineage tracing of biliary epithelial cells", Methods Mol Biol, 1905, pp.45~57 (2019)
44. Block GD, "Population expansion, clonal growth, and specific differentiation patterns in primary cultures of hepatocytes induced by HGF", SF, EGF and TGF alpha in a chemically defined(HGM)medium, 1996, pp.132, 1133~1149
45. Raynaud P, "Biliary differentiation and bile duct morphogenesis in development and disease", Int J Biochem Cell Biol, 43, pp.245~256 (2011)
46. Sampaziotis F, "Cholangiocytes derived from human induced pluripotent stem cells for disease modeling and drug validation", Nat Biotechnol, 33, pp.845~852 (2015)
47. Sampaziotis F, "Directed differentiation of human induced pluripotent stem cells into functional cholangiocyte-like cells", Nat Protoc, 12, pp.814~827 (2017)
48. Niu B, "SIRT1 upregulation protects against liver injury induced by a HFD through inhibiting CD36 and the NF‑κB pathway in mouse kupffer cells", Mol Med Report, 18, pp.1609~1615 (2018)
49. Li P, "The role of Kupffer cells in hepatic diseases", Mol Immunol, 85, pp.222~229 (2017)
50. Shi J, "Differentiation of human-induced pluripotent stem cells to macrophages for disease modeling and functional genomics", Curr Protoc Stem Cell Biol, 48, pp.e74~ (2019)
51. Chhabra A, "Human dendritic cell-derived induced pluripotent stem cell lines are not immunogenic", J Immunol, 198, pp.1875~1886 (2017)
52. Uygun BE, "Engineered liver for transplantation", Curr Opin Biotechnol, 24, pp.893~899 (2013)
53. Baptista PM, "The use of whole organ decellularization for the generation of a vascularized liver organoid", Hepatology, 53, pp.604~617 (2011)
54. Waring P, "Cell death induced by the Fas", Fas ligand pathway and its role in pathology, 1999, pp.77, 312~317
55. Tasnim F, "Generation of mature kupffer cells from human induced pluripotent stem cells", Biomaterials, 192, pp.377~391 (2019)
56. Lee SY, "Cell sources, liver support systems and liver tissue engineering : alternatives to liver transplantation", Int J Stem Cells, 8, pp.36~47 (2015)
57. Zhang J, "A decade of progress in liver regenerative medicine", Biomaterials, 157, pp.161~176 (2018)
58. He L, "Nano-engineered environment for nerve regeneration : scaffolds, functional molecules and stem cells", Curr Stem Cell Res Ther, 11, pp.605~617 (2016)
59. Langer R, "Advances in tissue engineering", J Pediatr Surg, 51, pp.8~12 (2016)
60. Li J, "Functional 3D human liver bud assembled from MSC-derived multiple liver cell lineages", Cell Transplant, 28, pp.510~521 (2019)
61. Yang W, "Decellularized liver scaffold for liver regeneration", Methods Mol Biol, 1577, pp.11~23 (2017)
62. Swinehart IT, "Extracellular matrix bioscaffolds in tissue remodeling and morphogenesis", Dev Dyn, 245, pp.351~360 (2016)
63. Lin P, "Assessing porcine liverderived biomatrix for hepatic tissue engineering", Tissue Eng, 10, pp.1046~1053 (2004)
64. Uygun BE, "Organ reengineering through development of a transplantable recellularized liver graft using decellularized liver matrix", Nat Med, 16, pp.814~820 (2010)
65. Park KM, "Decellularized liver extracellular matrix as promising tools for transplantable bioengineered liver promotes hepatic lineage commitments of induced pluripotent stem cells", Tissue Engineering Part A, 22, pp.449~460 (2016)
66. Coronado RE, "Hepatocytelike cells derived from human amniotic epithelial, bone marrow, and adipose stromal cells display enhanced functionality when cultured on decellularized liver substrate", Stem Cell Res, 38, pp.101471~ (2019)
67. Xiang JX, "Liver regeneration using decellularized splenic scaffold : a novel approach in tissue engineering", Hepatobiliary Pancreat Dis Int, 14, pp.502~508 (2015)
68. Liu P, "Hemocompatibility improvement of decellularized spleen matrix for constructing transplantable bioartificial liver", Biomed Mater, 14, pp.025003~ (2019)
69. Taylor DA, "Decellularized matrices in regenerative medicine", Acta Biomater, 74, pp.74~89 (2018)
70. Watari R, "A long-term culture system based on a collagen vitrigel membrane chamber that supports liver-specific functions of hepatocytes isolated from mice with humanized livers", J Toxicol Sci, 43, pp.521~529 (2018)
71. Khodabandeh Z, "Comparison of the expression of hepatic genes by human Wharton’s jelly mesenchymal stem cells cultured in 2D and 3D collagen culture systems", Iran J Med Sci, 41, pp.28~36 (2016)
72. Khodabandeh Z, "Hepatogenic differentiation capacity of human Wharton’s jelly mesenchymal stem cell in a co-culturing system with endothelial cells in matrigel", collagen scaffold in the presence of fetal liver extract, 2017, pp.10, 218~226
73. Nakai S, "Collagen vitrigel promotes hepatocytic differentiation of induced pluripotent stem cells into functional hepatocyte-like cells", Biol Open, 8, pp.bio042192~ (2019)
74. Ruoß M, "A standardized collagen-based scaffold improves human hepatocyte shipment and allows metabolic studies over 10 days", Bioengineering(Basel), 5, pp.86~ (2018)
75. Vasanthan KS, "Influence of 3D porous galactose containing PVA", gelatin hydrogel scaffolds on three-dimensional spheroidal morphology of hepatocytes, 2015, pp.26, 5345~
76. Ghaderi Gandomani M, "The enhancement of differentiating adipose derived mesenchymal stem cells toward hepatocyte like cells using gelatin cryogel scaffold", Biochem Biophys Res Commun, 491, pp.1000~1006 (2017)
77. Mohammadpour A, "Promoting hepatogenic differentiation of human mesenchymal stem cells using a novel laminin-containing gelatin cryogel scaffold", Biochem Biophys Res Commun, 507, pp.15~21 (2018)
78. German CL, "Type of endothelial cells affects HepaRG cell acetaminophen metabolism in both 2D and 3D porous scaffold cultures", J Appl Toxicol, 39, pp.461~472 (2019)
79. Yan Y, "Fabrication of viable tissue-engineered constructs with 3D cell-assembly technique", Biomaterials, 26, pp.5864~5871 (2005)
80. Verma P, "Formation and characterization of three dimensional human hepatocyte cell line spheroids on chitosan matrix for in vitro tissue engineering applications", In Vitro Cell Dev Biol Anim, 43, pp.328~337 (2007)
81. Feng ZQ, "The effect of nanofibrous galactosylated chitosan scaffolds on the formation of rat primary hepatocyte aggregates and the maintenance of liver function", Biomaterials, 30, pp.2753~2763 (2009)
82. Rajendran D, "Long-term liver-specific functions of hepatocytes in electrospun chitosan nanofiber scaffolds coated with fibronectin", J Biomed Mater Res A, 105, pp.2119~2128 (2017)
83. Fan L, "Preparation and characterization of hydroxypropyl chitosan modified with collagen peptide", Int J Biol Macromol, 93(Pt A), pp.636~643 (2016)
84. Li L, "Preparation and characterization of alginatechitosan microcapsule for hepatocyte culture", Methods Mol Biol, 1479, pp.199~206 (2017)
85. Fan J, "Preparation and characterization of a chitosan", galactosylated hyaluronic acid, J Biomater Sci Polym Ed, pp.2017, 28[DOI]
86. Fan J, "Preparation and characterization of chitosan", galactosylated hyaluronic acid scaffolds for primary hepatocytes culture, 2010, pp.21, 319~327
87. Tran NM, "An appropriate selection of a 3D alginate culture model for hepatic Huh-7 cell line encapsulation intended for viral studies", Tissue Eng Part A, 19, pp.103~113 (2013)
88. Lin N, "Differentiation of bone marrow-derived mesenchymal stem cells into hepatocyte-like cells in an alginate scaffold", Cell Prolif, 43, pp.427~434 (2010)
89. Lau TT, "Hepatogenesis of murine induced pluripotent stem cells in 3D micro-cavitary hydrogel system for liver regeneration", Biomaterials, 34, pp.6659~6669 (2013)
90. Shteyer E, "Reduced liver cell death using an alginate scaffold bandage : a novel approach for liver reconstruction after extended partial hepatectomy", Acta Biomater, 10, pp.3209~3216 (2014)
91. Varaa N, "Ameliorating effect of encapsulated hepatocyte-like cells derived from umbilical cord in high mannuronic alginate scaffolds on acute liver failure in rats", Iran J Basic Med Sci, 21, pp.928~935 (2018)
92. Shao H, "Carbon nanotube multilayered nanocomposites as multifunctional substrates for actuating neuronal differentiation and functions of neural stem cells", Biomaterials, 175, pp.93~109 (2018)
93. Abbasian M, "Scaffolding polymeric biomaterials : are naturally occurring biological macromolecules more appropriate for tissue engineering?", Int J Biol Macromol, 134, pp.673~694 (2019)
94. Oana C, "Natural macromolecules with protective and antitumor activity", Anticancer Agents Med Chem, 18, pp.675~683 (2018)
95. Song R, "Current development of biodegradable polymeric materials for biomedical applications", Drug Des Devel Ther, 12, pp.3117~3145 (2018)
96. Hanada S, "Enhanced in vitro maturation of subcultivated fetal human hepatocytes in three dimensional culture using poly-L-lactic acid scaffolds in the presence of oncostatin M", Int J Artif Organs, 26, pp.943~951 (2003)
97. Jiang J, "Efficacy of engineered liver tissue based on poly-L-lactic acid scaffolds and fetal mouse liver cells cultured with oncostatin M, nicotinamide, and dimethyl sulfoxide", Tissue Eng, 10, pp.1577~1586 (2004)
98. Wang B, "Functional maturation of induced pluripotent stem cell hepatocytes in extracellular matrix-a comparative analysis of bioartificial liver microenvironments", Stem Cells Transl Med, 5, pp.1257~1267 (2016)
99. Mobarra N, "Threedimensional nanofiberous PLLA", PCL scaffold improved biochemical and molecular markers hiPS cell-derived insulin-producing islet-like cells, 2018, pp.46(sup3), S685~S692
100. Mobarra N, "Hybrid poly-l-lactic acid", poly(ε-caprolactone)nanofibrous scaffold can improve biochemical and molecular markers of human induced pluripotent stem cell-derived hepatocyte-like cells, 2019, pp.234, 11247~11255
101. Ranucci CS, "Polymer substrate topography actively regulates the multicellular organization and liver-specific functions of cultured hepatocytes", Tissue Eng, 5, pp.407~420 (1999)
102. Kasuya J, "Reconstruction of 3D stacked hepatocyte tissues using degradable, microporous poly(d, l-lactide-co-glycolide)membranes", Biomaterials, 33, pp.2693~2700 (2012)
103. Liu T, "Hepatic differentiation of mouse embryonic stem cells in three-dimensional polymer scaffolds", Tissue Eng Part A, 16, pp.1115~1122 (2010)
104. Zhang K, "Aligned PLLA nanofibrous scaffolds coated with graphene oxide for promoting neural cell growth", Acta Biomater, 37, pp.131~142 (2016)
105. Zhang K, "Heparin", collagen encapsulating nerve growth factor multilayers coated aligned PLLA nanofibrous scaffolds for nerve tissue engineering, 2017, pp.105, 1900~1910
106. Kojima N, "Rapid hepatic cell attachment onto biodegradable polymer surfaces without toxicity using an avidinbiotin binding system", Biomaterials, 27, pp.4904~4910 (2006)
107. Brown JH, "Nanofibrous PLGA electrospun scaffolds modified with type I collagen influence hepatocyte function and support viability in vitro", Acta Biomater, 73, pp.217~227 (2018)
108. Bierwolf J, "Primary rat hepatocyte culture on 3D nanofibrous polymer scaffolds for toxicology and pharmaceutical research", Biotechnol Bioeng, 108, pp.141~150 (2015)
109. Hay DC, "Efficient differentiation of hepatocytes from human embryonic stem cells exhibiting markers recapitulating liver development in vivo", Stem Cells, 26, pp.894~902 (2008)
110. Si-Tayeb K, "Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells", Hepatology, 51, pp.297~305 (2010)
111. Siller R, "Small-moleculedriven hepatocyte differentiation of human pluripotent stem cells", Stem Cell Reports, 4, pp.939~952 (2015)

관련 논문AI추천